Shilpa Medicare (BOM:530549) Beneish M-Score: -2.29 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530549 Shilpa Medicare Ltd BOM:530549
76 GF Score
Price ₹619.55
GF Value ₹387.34
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Shilpa Medicare Beneish M-Score?

Shilpa Medicare BOM:530549 -2.88% 76 Beneish M-Score is -2.29 as of Jul. 18, 2026. GuruFocus rates BOM:530549 with a GF Score™ of 76/100 and a GF Value™ of ₹387.34 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 911 Drug Manufacturers companies, Shilpa Medicare ranks worse than 66.08% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.29 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Shilpa Medicare's Beneish M-Score or its related term are showing as below:

BOM:530549' s Beneish M-Score Range Over the Past 10 Years
Min: -2.84   Med: -2.39   Max: -1.88
Current: -2.29

During the past 13 years, the highest Beneish M-Score of Shilpa Medicare was -1.88. The lowest was -2.84. And the median was -2.39.


Shilpa Medicare Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Shilpa Medicare's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shilpa Medicare Beneish M-Score Chart

Shilpa Medicare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.88 -2.84 -2.52 -2.34 -2.29

Shilpa Medicare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.34 0.00 0.00 0.00 -2.29

BOM:530549 vs ZTS, UTHR: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shilpa Medicare's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shilpa Medicare Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shilpa Medicare's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Shilpa Medicare's Beneish M-Score falls into.


BOM:530549
76GF Score
Shilpa Medicare Ltd BOM:530549
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shilpa Medicare Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Shilpa Medicare for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9178+0.528 * 0.9717+0.404 * 1.1734+0.892 * 1.1962+0.115 * 0.9871
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * -0.026676-0.327 * 1.0172
=-2.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹5,189 Mil.
Revenue was ₹15,389 Mil.
Gross Profit was ₹10,785 Mil.
Total Current Assets was ₹11,098 Mil.
Total Assets was ₹37,056 Mil.
Property, Plant and Equipment(Net PPE) was ₹17,821 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹1,197 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0 Mil.
Total Current Liabilities was ₹8,481 Mil.
Long-Term Debt & Capital Lease Obligation was ₹1,851 Mil.
Net Income was ₹2,433 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹3,422 Mil.
Total Receivables was ₹4,726 Mil.
Revenue was ₹12,864 Mil.
Gross Profit was ₹8,760 Mil.
Total Current Assets was ₹9,857 Mil.
Total Assets was ₹33,107 Mil.
Property, Plant and Equipment(Net PPE) was ₹17,054 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹1,130 Mil.
Selling, General, & Admin. Expense(SGA) was ₹396 Mil.
Total Current Liabilities was ₹6,742 Mil.
Long-Term Debt & Capital Lease Obligation was ₹2,332 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(5188.5 / 15388.7) / (4725.924 / 12864.3)
=0.337163 / 0.367367
=0.9178

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(8760.4 / 12864.3) / (10784.6 / 15388.7)
=0.680985 / 0.700813
=0.9717

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (11097.7 + 17821) / 37056.1) / (1 - (9856.725 + 17054.445) / 33107.079)
=0.219597 / 0.187148
=1.1734

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=15388.7 / 12864.3
=1.1962

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1129.9 / (1129.9 + 17054.445)) / (1197.2 / (1197.2 + 17821))
=0.062136 / 0.06295
=0.9871

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 15388.7) / (396.247 / 12864.3)
=0 / 0.030802
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1851.3 + 8480.6) / 37056.1) / ((2332.05 + 6742.322) / 33107.079)
=0.278818 / 0.274092
=1.0172

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(2433.3 - 0 - 3421.8) / 37056.1
=-0.026676

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Shilpa Medicare has a M-score of -2.29 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.29 mean?
Shilpa Medicare (BOM:530549) has a Beneish M-Score of -2.29 as of Jul. 18, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Shilpa Medicare and its competitors. According to the industry distribution chart, Shilpa Medicare ranks #602 out of 911 companies in the Drug Manufacturers industry, placing it in the top 66.1%.
Is Shilpa Medicare's Beneish M-Score too high?
Shilpa Medicare's current Beneish M-Score is -2.29. Based on the distribution chart, Shilpa Medicare ranks #602 out of 911 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Shilpa Medicare has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shilpa Medicare's Beneish M-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shilpa Medicare ranks #602 out of 911 companies for Beneish M-Score. This places Shilpa Medicare in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Shilpa Medicare and its competitors. Shilpa Medicare's current Beneish M-Score is -2.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shilpa Medicare stock overvalued right now?
Based on GuruFocus' analysis, Shilpa Medicare (BOM:530549) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹387.34, compared to a current price of ₹619.55 — trading 59.9% above its estimated fair value. The current Beneish M-Score is -2.29. Shilpa Medicare's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Shilpa Medicare (BOM:530549), the current Beneish M-Score is -2.29 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shilpa Medicare (BOM:530549) Overvalued in 2026?

Based on GuruFocus' analysis, Shilpa Medicare stock appears to be overvalued. The current stock price of ₹619.55 is trading 59.9% above its estimated GF Value™ of ₹387.34. GuruFocus considers Shilpa Medicare to be Significantly Overvalued.

Key valuation signals for BOM:530549:

  • Beneish M-Score: -2.29
  • GF Value™: ₹387.34 vs. price of ₹619.55 (59.9% above fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the BOM:530549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shilpa Medicare Business Description

Other Exchanges SHILPAMED:India
Address Hyderabad Road, No. 12-6-214/A-1, Shilpa House, Raichur, KA, IND, 584135
Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company deals in high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery Systems, Peptides, Biotech products, and Specialty Chemicals etc. Its portfolio comprises various oncology and non-oncology-related APIs such as anastrozole, acebrophylline, busulphan, decitabine, etc, and finished dosage formulations such as apremilast tablets, clofarabine injection, docetaxel injection, etc., in various therapy areas. Its reporting segments are: Pharmaceutical product and services, which derive maximum revenue, Power sales, and Others. Geographically, the company generates maximum revenue from India, followed by Europe, the United States of America, and the Rest of the world.
76GF Score

Get the complete analysis for BOM:530549

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹619.55
Price
₹387.34
GF Value